An Open-Label Fixed-Sequence Study to Assess the Effects of Itraconazole and Rifampicin on the Single-Dose Pharmacokinetics of JNJ-53718678 in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 23 Aug 2016
At a glance
- Drugs Itraconazole (Primary) ; JNJ 53718678 (Primary) ; Rifampicin (Primary)
- Indications Respiratory syncytial virus infections
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 17 Aug 2016 Status changed from recruiting to completed.
- 20 Jun 2016 Planned End Date changed from 1 Jun 2016 to 1 Jul 2016.
- 12 Apr 2016 New trial record